Article (Scientific journals)
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease.
Ten Berg, Jurrien; Sibbing, Dirk; Rocca, Bianca et al.
2021In European Heart Journal, 42 (23), p. 2265-2269
Peer Reviewed verified by ORBi
 

Files


Full Text
ehab196.pdf
Author postprint (519.96 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Fibrinolytic Agents; Aged; Aortic Valve/surgery; Aortic Valve Stenosis/drug therapy/surgery; Consensus; Fibrinolytic Agents/therapeutic use; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Thrombosis/drug therapy/etiology/prevention & control; Transcatheter Aortic Valve Replacement/adverse effects; Treatment Outcome; Antithrombotic treatment;  Transcatheter aortic valve implantation
Abstract :
[en] Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic severe aortic stenosis, while the indication has recently broadened to younger patients at lower risk. Although thromboembolic and bleeding complications after TAVI have decreased over time, such adverse events are still common. The recommendations of the latest 2017 ESC/EACTS Guidelines for the management of valvular heart disease on antithrombotic therapy in patients undergoing TAVI are mostly based on expert opinion. Based on recent studies and randomized controlled trials, this viewpoint document provides updated therapeutic insights in antithrombotic treatment during and after TAVI.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Ten Berg, Jurrien ;  Department of Cardiology and Center for Platelet Function Research, St Antonius  ; The Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the
Sibbing, Dirk;  Privatklinik Lauterbacher Mühle am Ostersee, Seeshaupt, Germany. ; Department of Cardiology, Ludwig-Maximilians-Universität München (LMU Munich),  ; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart
Rocca, Bianca ;  Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy.
Van Belle, Eric;  Department of Interventional Cardiology for Coronary, Valves and Structural Heart
Chevalier, Bernard;  Ramsay Générale de Santé, ICPS, Hôpital Jacques Cartier, Massy, France.
Collet, Jean-Philippe ;  ACTION Study Group, Institut De Cardiologie, Hôpital Pitié-Salpêtrière (APHP)
Dudek, Dariusz;  Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland. ; Maria Cecilia Hospital, GVM Care&Research, Cotignola (RA), Italy.
Gilard, Martine;  Department of Cardiology, La Cavale Blanche University Hospital Center,
Gorog, Diana A ;  National Heart & Lung Institute, Imperial College, London, UK. ; Postgraduate Medical School, University of Hertfordshire, Hertfordshire, UK.
Grapsa, Julia ;  Department of Cardiology, Guys and St Thomas NHS Hospitals, London, UK.
Grove, Erik Lerkevang ;  Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
LANCELLOTTI, Patrizio  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie ; Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and
Petronio, Anna Sonia;  Department of Cardiology, University of Pisa, Pisa, Italy.
Rubboli, Andrea;  Department of Cardiovascular Diseases-AUSL Romagna, Division of Cardiology,
Torracca, Lucia;  Department of Cardiac Surgery, Humanitas University Hospital Rozzano-Milano,
Vilahur, Gemma;  Cardiovascular Program-ICCC, IR-Hospital de la Santa Creu i Sant Pau, CiberCV,
Witkowski, Adam;  Department of Interventional Cardiology and Angiology, National Institute of
Mehilli, Julinda;  Department of Cardiology, Ludwig-Maximilians-Universität München (LMU Munich),  ; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart  ; Department of Cardiology, Medizinische Klinik I, Landshut-Achdorf Hospital,
More authors (8 more) Less
Language :
English
Title :
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease.
Publication date :
14 June 2021
Journal title :
European Heart Journal
ISSN :
0195-668X
eISSN :
1522-9645
Publisher :
Oxford University Press, Gb
Volume :
42
Issue :
23
Pages :
2265-2269
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.
Available on ORBi :
since 18 May 2022

Statistics


Number of views
351 (0 by ULiège)
Number of downloads
418 (0 by ULiège)

Scopus citations®
 
87
Scopus citations®
without self-citations
80
OpenCitations
 
55

Bibliography


Similar publications



Contact ORBi